一个多层次的参数研究,用于模拟药物输送在支架动脉中的药物输送.
概括
这项研究模拟了冠状动脉支架中的视网氨酸药物输送. 血流和材料特性等关键因素显著影响药物积累,为心血管医学提供个性化支架设计的信息.
科学领域:
- 生物医学工程 生物医学工程
- 计算流体动力学的流体动力学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 冠状动脉疾病的治疗通常涉及支架.
- 药物释放支架 (DES) 旨在通过释放治疗剂来改善结果.
- 了解来自支架的药物分发对于优化疗效和最小化副作用至关重要.
研究的目的:
- 为了研究视网膜酸在支架冠状动脉中的动态行为和分布.
- 阐明支架设计和生理因素对药物释放和积累的影响.
- 为心血管医学中个性化支架应用提供见解.
主要方法:
- 开发了一种用于药物输送的多尺度计算模型,并应用于支架动脉片段.
- 使用光学连贯断层扫描 (OCT) 和X射线血管学重建了三维动脉几何.
- 有限元建模模拟了支架部署及其对药物分发的影响.
主要成果:
- 支架上的视网膜酸度的变化,血流速度,聚合物多孔性,动脉壁多孔性和药物透性显著改变了药物积累.
- 计算模型对关键参数的变化表现出敏感性,突出了它们在药物输送动态中的重要性.
- 药物分发模式受到支架特征和动脉环境之间的相互作用的影响.
结论:
- 计算建模提供了对造动脉中视网膜酸行为的宝贵见解.
- 优化支架参数和考虑患者特定因素可以提高治疗结果.
- 这项研究支持开发先进的,个性化的冠状动脉支架,以改善心血管治疗.
相关概念视频
Compartment Models: Two-Compartment Model
7.1K
The two-compartment model divides the body into central and peripheral compartments to account for varying blood perfusion rates among organs and tissues, affecting drug distribution. The central compartment includes blood and highly perfused tissues with rapid drug distribution, while the peripheral compartment contains tissues with slower drug distribution. After a single IV bolus dose, the drug concentration is high in plasma and low in tissues. The drug distribution between compartments...
7.1K
Cellular Membranes and Drug Transport
2.1K
Drugs must traverse multiple biological barriers, such as multi-layered skin, single-layered intestinal epithelium, and the plasma membrane, to reach their target sites within the body. The plasma membrane, a highly structured composite of phospholipids, carbohydrates, and proteins, is the cell's protective boundary, facilitating selective substance exchange.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
2.1K
Three-Compartment Open Model
1.2K
The three-compartment open model is a pharmacokinetic model used to describe the distribution and elimination of drugs following extravascular administration. It comprises a central compartment representing the plasma and two peripheral compartments. The highly perfused peripheral compartment represents organs and tissues with a rich blood supply, such as the liver, kidneys, and lungs. The scarcely perfused peripheral compartment represents tissues with lower blood supply, such as adipose...
1.2K
Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models
502
Physiological pharmacokinetic models, often called flow-limited or perfusion models, typically assume a swift drug distribution between tissue and venous blood, creating a rapid drug equilibrium. This premise is based on the idea that drug diffusion is extremely fast, and the cell membrane presents no barrier to drug permeation. In this scenario, where no drug binding occurs, the drug concentration in the tissue equals that of the venous blood leaving the tissue. This greatly simplifies the...
502
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
333
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
333
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
394
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
394


